ARCHIVES

NCI advisors approve recompetition of $62 million phase II contracts program.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal.

June 27, 2003

Freeman Reappointed President’s Cancer Panel Chairman

September 16, 1994

Cancer Screening Priorities Questioned In Dartmouth Study

March 28, 2003

NCCN Also to Warn Doctors. Amgen’s Pledges to Disclose Future Results.

February 23, 2007

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

Interest Picks Up In SBIR, NCI May Not Gave To Face Choice of Giving Money Back Or Paying to 500 Level

November 23, 1984